Filtered By:
Infectious Disease: COVID-19

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 5132 results found since Jan 2013.

Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up
Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00564-1. doi: 10.1016/j.anai.2023.08.002. Online ahead of print.NO ABSTRACTPMID:37557951 | DOI:10.1016/j.anai.2023.08.002
Source: Annals of Allergy, Asthma and Immunology - August 9, 2023 Category: Allergy & Immunology Authors: Sergey N Avdeev Viliya V Gaynitdinova Anna A Pozdnakova Svetlana Yu Chikina Karina A Kosobokova Source Type: research

Asthma in elderly and coronavirus disease 2019
Once the first wave of severe acute respiratory syndrome coronavirus 2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy.1 Symptoms persisting 3 to 6 months after acute coronavirus disease 2019 (COVID-19) (post –COVID-19 syndrome) have been described.2-5 Currently, there is a lack of information on post–COVID-19 consequences in elderly patients with asthma.
Source: Annals of Allergy, Asthma and Immunology - August 7, 2023 Category: Allergy & Immunology Authors: Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova Tags: Letters Source Type: research

Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up
Once the first wave of SARS-CoV-2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy1. Symptoms persisting 3 - 6 months after acute COVID-19 (post-COVID syndrome) have been described 2,3,4,5. Currently, there is a lack of information on post-COVID consequences in elderly patients with asthma. Asthma in elderly is known to have specific features, such as high comorbidity, use of multiple pharmacological agents, individual response to treatment, d...
Source: Annals of Allergy, Asthma and Immunology - August 7, 2023 Category: Allergy & Immunology Authors: Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova Tags: Letters Source Type: research

Did the coronavirus disease 2019 pandemic change asthma prevalence?
Ann Allergy Asthma Immunol. 2023 Aug;131(2):141-142. doi: 10.1016/j.anai.2023.05.022.NO ABSTRACTPMID:37536872 | DOI:10.1016/j.anai.2023.05.022
Source: Annals of Allergy, Asthma and Immunology - August 3, 2023 Category: Allergy & Immunology Authors: Rebecca Koenigsberg Mitchell H Grayson Source Type: research

HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

University of Alabama HIV researcher will head NIH ’s infectious disease institute
The infectious disease institute at the U.S. National Institutes of Health (NIH) will soon have its first new chief in nearly 4 decades. Jeanne Marrazzo, an expert on sexually transmitted infections, will become director of the National Institute of Allergy and Infectious Diseases (NIAID) in the fall. She will succeed Anthony Fauci, who stepped down in December 2022 after 38 years at NIAID’s helm. Marrazzo, 61, currently directs the Division of Infectious Diseases at the University of Alabama at Birmingham (UAB). A physician and epidemiologist, she has expertise in HIV prevention, vaginal infections, horm...
Source: ScienceNOW - August 2, 2023 Category: Science Source Type: news

Successful Treatment of Atopic Dermatitis with a Predominant Nipple Involvement by Abrocitinib During COVID-19 Pandemic: A Case Report
Source: Journal of Asthma and Allergy - August 1, 2023 Category: Allergy & Immunology Tags: Journal of Asthma and Allergy Source Type: research

Did the coronavirus disease 2019 pandemic change asthma prevalence?
Circulating coronaviruses have been associated with asthma exacerbations; however, early in the coronavirus disease 2019 pandemic, asthma exacerbations decreased.1 Similarly, other pandemic coronaviruses (sever acute respiratory syndrome [SARS] and Middle East Respiratory Syndrome) have not been associated with asthma exacerbations.2 However, as SARS coronavirus 2 (SARS-CoV-2) becomes less virulent and more like the circulating non-pandemic coronaviruses, there have been reports that asthma exacerbations are increasing.
Source: Annals of Allergy, Asthma and Immunology - August 1, 2023 Category: Allergy & Immunology Authors: Rebecca Koenigsberg, Mitchell H. Grayson Tags: Editorial Source Type: research

The Use and Teaching of Telemedicine in Allergy/Immunology Training Programs
AbstractPurpose of ReviewThe use of telemedicine has greatly increased since the onset of the coronavirus disease 2019 (COVID-19) pandemic. This review discusses the types of telemedicine, current telehealth curricula in medical education, and benefits and disadvantages of incorporation of telemedicine into Allergy/Immunology training programs.Recent FindingsThe majority of Allergists/Immunologists use telemedicine in their clinical practice with leaders in graduate medical education recommending inclusion of telemedicine in training. Fellows-in-training reported that use of telemedicine in Allergy/Immunology training duri...
Source: Current Allergy and Asthma Reports - August 1, 2023 Category: Allergy & Immunology Source Type: research